DeepMed Research

Northwestern University Human Resources

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1851-01-28

Employees: 5K

Market Cap: -

Website: https://www.venturecat.northwestern.edu

Clinical Trials

Patient Comfort During Dermatologic Procedures

Not Applicable

Completed

Conditions: Anxiety
Pain

Interventions: Procedure: Stress Ball
Procedure: Hand-holding

First Posted Date: 2016-06-29

Last Posted Date: 2021-12-06

Lead Sponsor: Northwestern University

Target Recruit Count: 135

Registration Number: NCT02816996

Locations: 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States

Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer

Phase 1

Completed

Conditions: Stage 0a Bladder Urothelial Carcinoma
Stage I Bladder Cancer
Recurrent Bladder Carcinoma
Stage 0is Bladder Urothelial Carcinoma

Interventions: Biological: BCG Solution
Other: Laboratory Biomarker Analysis
Biological: Pembrolizumab
Other: Pharmacological Study

First Posted Date: 2016-06-21

Last Posted Date: 2024-06-26

Lead Sponsor: Northwestern University

Target Recruit Count: 9

Registration Number: NCT02808143

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis

Early Phase 1

Withdrawn

Conditions: Polycythemia Vera
Thrombocytopenia
Primary Myelofibrosis
Myelofibrosis

Interventions: Procedure: Bone Marrow Aspiration and Biopsy
Other: Laboratory Biomarker Analysis
Biological: Siltuximab

First Posted Date: 2016-06-20

Last Posted Date: 2016-10-24

Lead Sponsor: Northwestern University

Registration Number: NCT02805868

IntelliCare Study: Artificial Intelligence in a Mobile (AIM) Intervention for Depression

Not Applicable

Completed

Conditions: Depression
Anxiety

Interventions: Behavioral: IntelliCare
Behavioral: Hub App with the Recommender System
Behavioral: Coaching

First Posted Date: 2016-06-16

Last Posted Date: 2023-04-04

Lead Sponsor: Northwestern University

Target Recruit Count: 301

Registration Number: NCT02801877

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma

Phase 2

Completed

Conditions: Malignant Glioma
Recurrent Glioblastoma

Interventions: Biological: Durvalumab
Other: Laboratory Biomarker Analysis
Procedure: Surgical Procedure
Biological: Tremelimumab

First Posted Date: 2016-06-09

Last Posted Date: 2022-04-18

Lead Sponsor: Northwestern University

Target Recruit Count: 36

Registration Number: NCT02794883

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Testing a Medication Risk Communication and Surveillance Strategy: The EMC2 Trial

Not Applicable

Completed

Conditions: High-risk Medications

Interventions: Behavioral: EMC2 Strategy

First Posted Date: 2016-05-27

Last Posted Date: 2021-01-27

Lead Sponsor: Northwestern University

Target Recruit Count: 1005

Registration Number: NCT02785458

Locations: 🇺🇸
Near North Health Services Corporation, Chicago, Illinois, United States

Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps

Completed

Conditions: Colon Polyps

Interventions: Procedure: Endoscopic Mucosal Resection

First Posted Date: 2016-05-25

Last Posted Date: 2017-06-16

Lead Sponsor: Northwestern University

Target Recruit Count: 500

Registration Number: NCT02782793

Locations: 🇺🇸
UCLA Medical Center, Los Angeles, California, United States
🇺🇸
University of Colorado, Denver, Denver, Colorado, United States
🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

and more 1 locations

Evaluation of Perioperative Celecoxib for Hip Arthroscopy

Not Applicable

Completed

Conditions: Hip Labral Tears

Interventions: Drug: placebo
Drug: Celecoxib

First Posted Date: 2016-05-20

Last Posted Date: 2019-09-23

Lead Sponsor: Northwestern University

Target Recruit Count: 98

Registration Number: NCT02779166

Feasibility of a Single-operator Peroral Cholangiopancreatioscopy System (SpyGlass)

Withdrawn

Conditions: Common Bile Duct Stones
Bile Duct Strictures

Interventions: Procedure: ERCP with cholangioscopy

First Posted Date: 2016-05-18

Last Posted Date: 2020-12-04

Lead Sponsor: Northwestern University

Registration Number: NCT02776709

Locations: 🇺🇸
UCLA Medical Center, Los Angeles, California, United States
🇺🇸
University of Colorado, Denver, Denver, Colorado, United States
🇺🇸
Ochsner Medical Center, New Orleans, Louisiana, United States

and more 2 locations

Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis

Phase 2

Terminated

Conditions: HER2/Neu Negative
Breast Carcinoma Metastatic in the Brain
Estrogen Receptor Negative
HER2/Neu Positive
Progesterone Receptor Negative
Recurrent Breast Carcinoma
Stage IV Breast Cancer

Interventions: Procedure: Cognitive Assessment
Drug: Palbociclib
Procedure: Quality-of-Life Assessment
Biological: Trastuzumab

First Posted Date: 2016-05-17

Last Posted Date: 2020-04-14

Lead Sponsor: Northwestern University

Target Recruit Count: 12

Registration Number: NCT02774681

Locations: 🇺🇸
Northwestern Lake Forest Hospital, Lake Forest, Illinois, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
Houston Methodist Hospital/Houston Methodist Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy